Showing 4,141 - 4,160 results of 15,659 for search '(( significant decrease decrease ) OR ( significantly i decrease ))~', query time: 0.57s Refine Results
  1. 4141
  2. 4142

    Flowchart of analysis. by Fanqiang Meng (4786071)

    Published 2025
    “…</p><p>Results</p><p>A total of 168,693 primary KA patients were included during the study period. The migration rate decreased from 17.6% in 2013 to 7.6% in 2018 (<i><i>P</i></i> < 0.001). …”
  3. 4143
  4. 4144
  5. 4145
  6. 4146

    Overview of selected datasets. by Tejaswini Baral (14320736)

    Published 2025
    “…</p><p>Results</p><p>Our analysis revealed statistically significant alpha diversity differences in West Africa with decreased microbial diversity in pulmonary tuberculosis patients after two months of antitubercular therapy. …”
  7. 4147

    Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”
  8. 4148
  9. 4149
  10. 4150

    Mass spectrometric analyses for crystallins. by Akosua K. Boateng (21672931)

    Published 2025
    “…Previous <i>in-vitro</i> studies of recombinant βA3ΔG91 showed defective folding, decreased solubility, and aberrant oligomerization of βA3ΔG91 with other crystallins. …”
  11. 4151

    RNA-seq data showing top 15 downregulated genes. by Akosua K. Boateng (21672931)

    Published 2025
    “…Previous <i>in-vitro</i> studies of recombinant βA3ΔG91 showed defective folding, decreased solubility, and aberrant oligomerization of βA3ΔG91 with other crystallins. …”
  12. 4152

    RNA-seq data showing top 15 upregulated genes. by Akosua K. Boateng (21672931)

    Published 2025
    “…Previous <i>in-vitro</i> studies of recombinant βA3ΔG91 showed defective folding, decreased solubility, and aberrant oligomerization of βA3ΔG91 with other crystallins. …”
  13. 4153
  14. 4154
  15. 4155
  16. 4156
  17. 4157

    Patient status overview. by Farayi Kaseke (19560197)

    Published 2024
    “…Age was a significant risk factor, with individuals aged 45–65 and those over 65 years showing higher adjusted hazard ratios 3.4 (95% CI: 1.42, 8.36) and 3.7(95%CI:1.44, 9.36), respectively, relative to those below 45 years of age. …”
  18. 4158

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…In this work, the role of 5.56 mol % 1,3-dioxolane (DIOX) in mixed methane hydrate formation was investigated in terms of thermodynamics, kinetics, and morphology. …”
  19. 4159

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…In this work, the role of 5.56 mol % 1,3-dioxolane (DIOX) in mixed methane hydrate formation was investigated in terms of thermodynamics, kinetics, and morphology. …”
  20. 4160

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…In this work, the role of 5.56 mol % 1,3-dioxolane (DIOX) in mixed methane hydrate formation was investigated in terms of thermodynamics, kinetics, and morphology. …”